The observation that the proband did not experience HUS recurrence in the kidney graft and exhibits good a graft function at the 5-year follow-up after transplantation can be explained by the transplant correcting the CD46 genetic defect, since endothelial cells within the kidney allograft express normal CD46. The gene discussed is CD46; the disease is hemolytic-uremic syndrome.